Loading...
Age-associated changes in the immune system may influence the response to anti-PD1 therapy in metastatic melanoma patients
Anti-PD1 treatment has improved the survival of metastatic melanoma patients, yet it is unknown which patients benefit from the treatment. In this exploratory study, we aimed to understand the effects of anti-PD1 therapy on the patients’ immune system and discover the characteristics that would resu...
Na minha lista:
| Udgivet i: | Cancer Immunol Immunother |
|---|---|
| Main Authors: | , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Springer Berlin Heidelberg
2020
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7183505/ https://ncbi.nlm.nih.gov/pubmed/32036449 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00262-020-02497-9 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|